Collegium Pharmaceutical Inc (COLL) Insider Trading
- $4,316,951.25
- $64,281,832.82
- March 14, 2025
- Michael Thomas Heffernan
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 3, 2020 | CTO | 5,967 | $19.24 | Sell | $114,805.08 | |
Oct. 15, 2020 | EVP | 7,060 | $20.82 | Sell | $146,989.20 | |
July 13, 2020 | EVP | 1,429 | $17.01 | Sell | $24,307.29 | |
June 1, 2020 | CEO | 70,676 | $21.53 | Sell | $1,521,654.28 | |
May 13, 2020 | CTO | 7,989 | $21.67 | Sell | $173,121.63 | |
May 13, 2020 | Director | 19,254 | $21.63 | Sell | $416,464.02 | |
May 13, 2020 | EVP | 4,434 | $22.61 | Sell | $100,252.74 | |
Jan. 21, 2020 | Director | 295,287 | $21.93 | Sell | $6,475,643.91 | |
Jan. 14, 2020 | EVP | 1,321 | $23.87 | Sell | $31,532.27 | |
Nov. 8, 2019 | Director | 25,000 | $19.33 | Sell | $483,250.00 | |
Nov. 7, 2019 | CEO | 64,821 | $18.77 | Sell | $1,216,690.17 | |
Aug. 29, 2019 | Director | 22,106 | $11.65 | Sell | $257,534.90 | |
July 15, 2019 | Director | 25,000 | $11.26 | Sell | $281,500.00 | |
July 11, 2019 | EVP | 2,857 | $12.31 | Sell | $35,169.67 | |
June 17, 2019 | Director | 25,000 | $11.37 | Sell | $284,250.00 | |
June 3, 2019 | CEO | 7,436 | $11.59 | Sell | $86,183.24 | |
May 31, 2019 | CEO | 5,851 | $11.52 | Sell | $67,403.52 | |
May 15, 2019 | Director | 25,000 | $12.84 | Sell | $321,000.00 | |
April 15, 2019 | Director | 25,000 | $15.09 | Sell | $377,250.00 | |
March 15, 2019 | Director | 25,000 | $17.17 | Sell | $429,250.00 | |
Feb. 15, 2019 | Director | 25,000 | $14.81 | Sell | $370,250.00 | |
Jan. 15, 2019 | Director | 25,000 | $15.56 | Sell | $389,000.00 | |
Dec. 17, 2018 | Director | 25,000 | $18.18 | Sell | $454,500.00 | |
Nov. 15, 2018 | Director | 25,000 | $16.60 | Sell | $415,000.00 | |
Oct. 15, 2018 | Director | 25,000 | $16.53 | Sell | $413,250.00 | |
June 21, 2018 | Insider | 10,000 | $27.92 | Sell | $279,200.00 | |
June 12, 2018 | Chairman | 150,000 | $25.27 | Sell | $3,790,500.00 | |
June 12, 2018 | Insider | 4,096 | $27.00 | Sell | $110,592.00 | |
June 1, 2018 | COO | 79,683 | $22.59 | Sell | $1,800,038.97 | |
April 19, 2018 | Chairman | 44,400 | $26.00 | Sell | $1,154,400.00 | |
Jan. 23, 2018 | Chairman | 20,000 | $25.01 | Sell | $500,200.00 | |
Jan. 19, 2018 | Chairman | 20,000 | $22.50 | Sell | $450,000.00 | |
Jan. 10, 2018 | Insider | 6,928 | $19.07 | Sell | $132,116.96 | |
Dec. 8, 2017 | Major Shareholder | 1,000,000 | $17.34 | Sell | $17,340,000.00 | |
Nov. 21, 2017 | Insider | 4,601 | $17.25 | Sell | $79,367.25 | |
Nov. 17, 2017 | CTO | 4,029 | $17.00 | Sell | $68,493.00 | |
Nov. 15, 2017 | CEO | 50,000 | $15.53 | Sell | $776,500.00 | |
May 12, 2017 | Insider | 10,000 | $9.18 | Buy | $91,800.00 | |
Aug. 12, 2016 | Director | 2,375 | $10.59 | Buy | $25,151.25 | |
May 12, 2015 | Director | 150,000 | $12.00 | Buy | $1,800,000.00 | |
May 12, 2015 | Major Shareholder | 200,000 | $12.00 | Buy | $2,400,000.00 |
Insiders are both buying and selling Collegium Pharmaceutical Inc stock.
The insider traders at Collegium Pharmaceutical Inc are: Michael Thomas Heffernan, Joseph Ciaffoni, Shirley R Kuhlmann, Scott Dreyer, Alison B Fleming, Colleen Tupper, Paul Brannelly, David Hirsch, Longitude Capital Partners, Ll, Thomas B Smith, John A Fallon, Garen G Bohlin, and John Gordon Freund
The most active insider trader at Collegium Pharmaceutical Inc is Michael Thomas Heffernan with 22 trades.
Longitude Capital Partners, Ll has sold the most Collegium Pharmaceutical Inc stock with a total value of $34,680,000.00.
Longitude Capital Partners, Ll has bought the most Collegium Pharmaceutical Inc stock with a total value of $4,800,000.00.
The most recent insider trade for Collegium Pharmaceutical Inc was on March 14, 2025.
The single biggest insider buy for Collegium Pharmaceutical Inc was from Longitude Capital Partners, Ll with a total value of $2,400,000.00 on May 12, 2015.
The single biggest insider sell for Collegium Pharmaceutical Inc was from Longitude Capital Partners, Ll with a total value of $17,340,000.00 on Dec. 8, 2017.